TAVR

Edwards Lifesciences will present at two upcoming investor conferences: the Barclays Global Healthcare Conference on March 11th and the Leerink Partners Global Healthcare Conference on March 13th. Management will discuss strategic priorities, advancements in structural heart disease technologies like TAVR, and critical care monitoring. They will also touch on market dynamics, R&D, and the company’s pipeline. Webcasts will be available on the Edwards Lifesciences investor relations website.